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Abstract
Background: Hypertension has a rapidly growing disease burden among older persons in low-income
countries (LICs) that is often inadequately diagnosed and treated. Yet, most LIC research on hypertension
is based on cross-sectional data that does not allow inferences about the onset or persistence of
hypertension, its correlates, and changes in hypertension as individuals become older.
Data and methods: The Mature Adults Cohort of the Malawi Longitudinal Study of Families and Health
(MLSFH-MAC) is used to provide among the first panel analyses of hypertension for older individuals in a
sub-Saharan LIC using blood pressure measurements obtained in 2013 and 2017.
Findings: High blood pressure is very common among mature adults aged 45+ in rural Malawi, and
hypertension is more prevalent among older as compared to middle-aged respondents. Yet, in panel
analyses for 2013-17, we find no increase in the prevalence of hypertension as individuals become older.
Hypertension often persists over time, and the onset of hypertension is predicted by factors such as
being overweight/obese, or being in poor physical health. Otherwise, however, hypertension has few
socioeconomic predictors. There is also no gender differences in the level, onset or persistence in
hypertension. While hypertension is associated with several negative health or socioeconomic
consequences in longitudinal analyses, cascade-of-care analyses document significant gaps in the
diagnosis and treatment of hypertension.
Conclusions: Our findings indicate that hypertension and related high cardiovascular risks are
widespread, persistent, and often not diagnosed or treated in this rural sub-Saharan population of older
individuals. Prevalence, onset and persistence of hypertension are common across all subgroupsincluding, importantly, both women and men. While age is an important predictor of hypertension risk,
even in middle ages 45-55 years, hypertension is already widespread. Hypertension among adults aged
45+ in Malawi is thus more similar to a "generalized epidemic" than in high-income countries where
cardiovascular risk has strong socioeconomic gradients and untreated hypertension particularly prevalent
in vulnerable subsets of older persons.
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Background: Hypertension has a rapidly growing disease burden among older persons in
low-income countries (LICs) that is often inadequately diagnosed and treated. Yet, most
LIC research on hypertension is based on cross-sectional data that does not allow inferences
about the onset or persistence of hypertension, its correlates, and changes in hypertension as
individuals become older.
Data and methods: The Mature Adults Cohort of the Malawi Longitudinal Study of Families
and Health (MLSFH-MAC) is used to provide among the first panel analyses of hypertension
for older individuals in a sub-Saharan LIC using blood pressure measurements obtained in
2013 and 2017.
Findings: High blood pressure is very common among mature adults aged 45+ in rural
Malawi, and hypertension is more prevalent among older as compared to middle-aged respondents. Yet, in panel analyses for 2013–17, we find no increase in the prevalence of hypertension as individuals become older. Hypertension often persists over time, and the onset
of hypertension is predicted by factors such as being overweight/obese, or being in poor
physical health. Otherwise, however, hypertension has few socioeconomic predictors. There
is also no gender differences in the level, onset or persistence in hypertension. While hypertension is associated with several negative health or socioeconomic consequences in longitudinal analyses, cascade-of-care analyses document significant gaps in the diagnosis and
treatment of hypertension.
Conclusions: Our findings indicate that hypertension and related high cardiovascular risks
are widespread, persistent, and often not diagnosed or treated in this rural sub-Saharan population of older individuals. Prevalence, onset and persistence of hypertension are common
across all subgroups—including, importantly, both women and men. While age is an important predictor of hypertension risk, even in middle ages 45–55 years, hypertension is already widespread. Hypertension among adults aged 45+ in Malawi is thus more similar to a
“generalized epidemic” than in high-income countries where cardiovascular risk has strong
socioeconomic gradients and untreated hypertension particularly prevalent in vulnerable
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Hypertension without Conventional Risk Factors

1. I NTRODUCTION
Hypertension is not only widespread in higher-income countries. To the contrary, levels of
hypertension are actually often higher in sub-Saharan African (SSA) and low- and middleincome countries (LMICs) as compared to high-income countries (HICs) (Figure 1A and
[1, 2]). Among adults over the age of 18 in SSA as a whole, despite an overall young age
structure, more than 20% of men and women have hypertension (systolic BP ≥ 140 mmHg
or diastolic BP ≥ 90 mmHg) [1, 2]. The diagnosis and treatment of this widespread hypertension is often inadequate [3]. Moreover, the high prevalence of hypertension in SSA
and/or LMIC contrasts with an often low prevalence of “classic” risk factors (i.e., high
rates of obesity, unhealthy life styles and reduced physical activity) [1, 2, 4]. In global comparison, for example, women in SSA have among the highest prevalence of hypertension,
while they also are among the leanest in the world (Figure 1A+B).
This prevalence and number of individuals in need of hypertension care is expected
to grow substantially as LMICs further develop and undergo rapid population aging during the coming decades [1, 5–7]. This rise in hypertension is related to a broader shift in
the burden of disease in LMICs towards non-communicable diseases (NCDs) that have
become leading causes of adult morbidity and mortality in sub-Saharan African (SSA)
countries [8]. The shifting disease burden towards NCDs, along with a gradual aging of
global populations [9], has been described as a frontier in global health research [10] that is
likely to regain focus once the Covid-19 pandemic has receded [7, 11].
Figure 1: Prevalence of high blood pressure and obesity by sex across different regions
in the world (2015, in %, age-standardized)

Sub−Saharan Africa
High−income countries
Other countries

0.15
0.20
0.25
0.30
0.35
Women: prevalence of raised blood pressure

Men: prevalence of obesity (BMI >= 30)
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Source: Own calculations based on NCD-RisC [2]. High blood pressure is defined by NCD-RisC as systolic BP
≥ 140 mmHg or diastolic BP ≥ 90 mmHg. Obesity is defined as BMI ≥ 30. Prevalence of high blood pressure
and obesity are age-standardized so that they are better comparable across countries.
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Despite the importance of understanding and addressing hypertension in SSA, an important limitation of existing hypertension research in SSA, and more broadly in lowincome countries (LICs), is that the findings are largely based on cross-sectional data.
Importantly, cross-sectional data are not informative about the incidence of hypertension
as individuals age, and they cannot differentiate persistent hypertension from temporary
episodes of elevated blood pressure. Age-gradients of hypertension observed in crosssectional data can arise from cohort differences, and such age gradients thus may not
reflect changes in hypertension prevalence as individuals become older. Hence, if agebased increases in hypertension are used to create thresholds for targeting care efforts,
cross-sectional data may misguide clinical decisions. Cross-sectional studies are also limited in their ability to identify the extent to which enhancing awareness and knowledge
about blood pressure will improve blood pressure levels over time [12, 13]. Ultimately,
only analyses of longitudinal data can provide a better understanding of hypertension as
a dynamic process that is interrelated with individual aging and socioeconomic changes.
Yet, very few such studies have been conducted in LICs.
Our study is among the first longitudinal analyses of widespread hypertension among
aging global poor using panel data from a low-income country. The individuals that we
study had lifecourse experiences that are typical for the aging global poor: They lived most
of their lives with per capita incomes of less than $1/day [14]. Fertility was high in these
cohorts [15], the status of women was generally low, and income generation through subsistence agriculture and small scale agriculture entailed relatively high levels of physical
activity [16]. Older study participants were born when under-5 mortality was almost one
out of three [5], and period life expectancies at birth were around 35 years in the 1950s,
and remained below 46 years until the early 2000s [5]. All members of our study population have survived sustained poverty, frequent undernutrition, and epidemics. Health at
older ages is often poor, and individuals experience accelerated aging with an early onset
of morbidity across multiple domains [8, 17–19].

2. M ETHODS
Data: Data for this study come from the Mature Adults Cohort of the Malawi Longitudinal

Study of Families and Health (MLSFH-MAC), which to our best knowledge is currently
the only population-based cohort study of adults in a SSA LICs that collects longitudinal
information on blood pressure along with data on hypertension prevalence, incidence, treatment, awareness and knowledge [16, 20]. The MLSFH is based in Malawi, one of the
poorest countries in the world that is ranked 174 out of 189 countries in terms of the Human Development Index in 2019 (HDI2019 = .485) [21] and has a per-capita GDP equal to
about 5% of the global average [22]. In rural areas, where our study is based and most
Malawians (85%) live, about 60% of the rural population was considered poor in 2016/17,
thus having a total consumption that does not provide 2,400 calories per day per person
[23].
Version: 10th February, 2022 (11:52am)
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The MLSFH-MAC study population consists of adults aged 45+ years living in rural
areas in three districts in Malawi (Mchinji, Balaka, Rumphi). Baseline enrollment in 2012
was 1,266 individuals, and the cohort was followed up in 2013, 2017, and 2018, when
each time additional eligible MLSFH respondents reaching age 45 years were enrolled in
MLSFH-MAC. An MLSFH-MAC Cohort Profile provides detailed information about sampling procedures, study instruments, attrition/follow-up rates [16], and summary statistics for the study population are provided in the Supplemental Materials (Tables S.1–S.2).
Life expectancy at birth is currently ≈63 years, and life expectancy at age 45 is currently
≈28 years [5]. Healthy life expectancy at age 45 is estimated around 22 years [8], and
older adults can expect to live a large proportion of their later years subject to physical
limitations on their activities [24].
We focus on MLSFH-MAC respondents with longitudinal measurements of blood pressure in 2013 (baseline) and the 2017 follow-up. The mean age is about 60 years in 2017, with
37% of respondents being age 45–54 years and 14% age 75+ years. 60% of the study population is female, and one quarter is Muslim. The study population is characterized by low
levels of formal schooling (30% of respondents have no formal education, and 64% have
only primary education). 58% of female and 94% of male respondents were married in
2017, and about half of the respondents resided in a house with a metal/tiled roof. The
HIV prevalence for the MLSFH-MAC cohort was 8% in 2017, with HIV+ individuals concentrated at ages 45-49 years. The majority of respondents (66%) have body mass index
(BMI) that is within the normal range (18 ≤ BMI ≤ 25) or are underweight (17% have BMI
below 18). While only a small fraction of the study population is overweight (12%) or
obese (4.7%), women are more likely to fall into these high risk BMI categories.
Measurement of blood pressure in MLSFH-MAC: Blood pressure (BP) in MLSFH-MAC was

measured in 2013 and 2017 following the protocol developed by the Health and Retirement Study (HRS) [25]. Three BP measurements on the left arm were taken about 1 minute
apart in a sitting position in a chair, using an upper arm automated BP monitor (Omron
HEM-780N). BP data is available for 1,227 respondents aged 45+ in 2013 and 1,512 in 2017.
Longitudinal BP measurements are available for 1,075 MLSFH-MAC participants. Respondents who measured BP above 160 mmHg systolic and/or 110 mmHg diastolic were given
a referral for follow up with a doctor or medical professional, but were not provided any
other information about blood pressure. Virtually all respondents (e.g., 99% of participants in 2017) agreed to the BP measurement. Prior to the BP measurement, respondents
were asked if they have been diagnosed with hypertension by a doctor or medical personnel in the last two years before the survey, and if they are currently taking medication
for reducing BP. Respondents’ knowledge about the risks associated with high BP was
elicited by asking why it is important for individuals to know their blood pressure, and
the importance that respondents attributed to knowing their BP was assessed through a
question asking how far (long) they would be willing to walk to a clinic to obtain a (free)
BP measurement. Additionally, the 2017 survey included questions on knowledge about
Version: 10th February, 2022 (11:52am)
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BP and associated risk factors, and a set of questions focused on the ability of respondents
to recognize symptoms associated with high BP.
Approach: Individuals are defined as pre-hypertensive if 120 ≤ BPsys < 140 or 80 ≤

BPdia < 90, as hypertensive stage 1 if 140 ≤ BPsys < 160 or 90 ≤ BPdia < 100 and hypertensive stage 2 if BPsys ≥ 160 or BPdia ≥ 100, where BPsys denotes systolic and BPdia diastolic blood pressure. Onset of hypertension is defined as having normal blood pressure or
pre-hypertension at baseline (2013), and having Stage 1 or 2 hypertension at follow-up in
2017. In 85% of cases, systolic BP determines the hypertension classification. Persistent hypertension is defined as being Stage 1 or Stage 2 hypertensive at both baseline (2013) and
follow-up (2017). Persistent Stage 2 hypertension is defined as being Stage 2 hypertensive
in both 2013 and 2017.
The “cascade of care” concept [26, 27] is used to measure linkage to care, health seeking
behavior, and effective treatment for individuals with hypertension. The cascade represents the proportion of individuals who reach each separate stage of care, conditional on
being included in the previous stage, and it is useful to identify the stages of the disease
care cascade where the management of a disease fails. For hypertension care, the following
cascade stages are defined: (1) being hypertensive (47% and 46% of all respondents in 2013
and 2017 respectively), either based on measured BP (90% and 84% of hypertensive cases
in 2013 and 2017 respectively) and/or a reported diagnosis (22% or 39% of hypertensive
cases in 2013 and 2017 respectively); (2) diagnosis of hypertension by a doctor or medical
personnel within 2 years prior to the survey; (3) treatment of high BP with medication, and
(i) treatment for high BP and controlled BP (= measured BP does not indicate hypertension
at time of survey).
We employ standard regression analysis and focus on the results from the longitudinal
analyses of hypertension during 2013–17, which are enabled by the longitudinal cohort
information available in MLSFH-MAC. Related cross-sectional or complementary results
are reported in the Supplemental Materials.
Ethics Approval: This research based on the MLSFH-MAC was approved by the IRB at the

University of Protocol #815016) and the College of Medicine (now Kamuzu University of
Health Sciences) in Malawi (COMREC Protocol #P.01/12/1165).

3. R ESULTS
Prevalence of hypertension, hypertension incidence and persistent hypertension: At base-

line in 2013, 42.5% of mature adults were hypertensive (23.5% Stage 1, 19% Stage 2; Table 1). In multivariate analyses, prevalence of hypertension is higher at older ages, is similar between women and men, varies across MLSFH study regions and is not associated
with having obtained formal schooling (Supplemental Table S.3).
Hypertension prevalence is similar between the longitudinal sample (Table 1), which is
used for our cohort analyses of changes in hypertension 2013–17, and the cross-sectional
sample at baseline in 2013, except for a lower prevalence of Stage 1 and Stage 2 hyperVersion: 10th February, 2022 (11:52am)
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Table 1: Prevalence of hypertension in 2013, and onset and persistence of hypertension
during 2013–17 among MLSFH Mature Adults
Prevalence of
Hypertension

Change in Hypertension 2013–17
(Longitudinal Sample)

2013
Baseline
Sample

2013
Longitud.
Sample

Onset
Hypertension

Persistent
Hypertension

Persistent
Stage 2
Hypertens.

Normal blood pressure
Pre-hypertension
Stage 1 hypertension
State 2 Hypertension

25.3%
32.1%
23.5%
19.0%

26.0%
33.0%
23.2%
17.8%

10.5%
28.5%
–
–

–
–
59.1%
83.1%

–
–
–
58.4%

Obs (N)

1,229

1,065

tension that is due to selective survival (hypertension predicts mortality, but not other
attrition, see below).
Cohort analyses show that 10.5% respondents with normal BP at baseline were hypertensive (Stage 1 or 2) by 2017; this proportion increases to 28.5% among those who were
pre-hypertensive at baseline. 59% and 83% of respondents with Stage 1 or Stage 2 hypertension at baseline respectively were still hypertensive (Stage 1 or 2) by 2017. 58% of those
with Stage 2 hypertension were still Stage 2 hypertensive by 2017. These patterns of prevalence, onset and persistence of hypertension among adults aged 45+ are very similar for
men and women, and with one exception (onset of hypertension among respondents classified as pre-hypertensive at baseline), not statistically different (Supplemental Table S.4).
Several factors are associated with the onset or persistence of hypertension among
adults aged 45+ during 2013–17 (Table 2). There is a weak indication that women are more
likely to have an onset of hypertension, but otherwise no clear gender difference in the
persistence of hypertension over time. Being overweight or obese increases the odds of
hypertension onset and the persistence of hypertension, and poor physical health (low
SF12 physical score) and nutritional stress (no consumption of fish or meat in last seven
days) predict the onset of hypertension. The same factors also predict changes in systolic
BP among respondents not hypertensive at baseline, and in some cases also for the overall
study population or other subgroups. Being HIV-positive or Muslim protects against increases in systolic BP. Being married is associated with increases in blood pressure and the
persistence of hypertension, contrary to common findings that marriage often found to be
protective for cardiovascular health [28]. Notably wealth (various indicators), schooling
and grip strength are not predictors of the onset/persistence of hypertension or changes
in blood pressure (Supplemental Table S.6).
Blood pressure and aging: Table 3 shows only modest within-person increases in systolic

blood pressure during 2013–17: For women aged 45–54 years there is an annual increase
in systolic BP of .94 base points per year of age during 2013–17 (similar to the age gradient
Version: 10th February, 2022 (11:52am)
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1.43
[-2.19,5.06]
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≈625

≈620

-2.34∗∗
[-4.00,-0.67]

≈435

1.31∗
[1.02,1.68]

≈410

0.34
[-2.45,3.14]

≈190

≈175

-0.47
[-5.55,4.60]

1.22
[-7.05,9.49]

-8.34
[-18.8,2.14]
-4.50
[-21.5,12.5]

4.54
[-6.85,15.9]

6.55
[-1.64,14.7]

10.0∗
[2.28,17.8]

5.31+
[-0.27,10.9]

Change in
systolic
BP
2013–17
(OLS Coef)

≈1030

-1.48+
[-3.03,0.074]

3.02+
[-0.29,6.33]

-5.57∗∗
[-8.65,-2.50]
-2.07
[-6.74,2.59]

-4.61∗
[-8.82,-0.39]

3.74∗
[0.70,6.78]

4.55∗∗
[1.40,7.71]

1.23
[-0.83,3.28]

Change in
systolic
BP
2013–17
(OLS Coef)

≈1030

-0.65
[-1.51,0.21]

2.46∗∗
[0.72,4.20]

-1.25
[-3.53,1.02]
-0.41
[-2.95,2.14]

-3.79∗∗
[-6.43,-1.16]

1.45+
[-0.031,2.92]

0.55
[-1.06,2.16]

1.24∗
[0.20,2.29]

Change in
diastolic
BP
2013–17
(OLS Coef)

Combined

All respondents

Notes: Tables shows the results of OLS regressions (for change in blood pressure) or logistic regressions (for onset or persistence of hypertension) on the
on the predictor variables, controlling additionally for age, gender and region. level. Analyses include all MLSFH-MAC respondents with both 2013
and 2017 BP measurement. Within-person change in BP is calculated as the difference of 2017 BP minus 2013 BP. Outliers in BP change are eliminated as
they may reflect measurement errors (outliers are defined as being in the 1st or 99th percentile of the 2013–17 change in BP, p-values (robust std. errors):
p < 0.10, ∗ p < 0.05, ∗∗ p < 0.01.

Observations

Other/none

1.15
[0.79,1.68]

0.2
[0.019,2.11]

SF12 Physical health score (z-score)
SF12 Physical health z-score
0.77∗
[0.62,0.95]

-4.04
[-12.4,4.36]

0.55
[0.24,1.28]

1.02
[0.47,2.23]
0.58
[0.24,1.39]

0.63
[0.26,1.56]

Low protein consumption (Ref.: Ate fish or meat at least once in last 7 days)
Ate no fish or meat
2.13∗∗
5.56∗∗
1.01
0.055
in last 7 days
[1.36,3.34]
[2.42,8.70]
[0.52,1.99]
[-5.51,5.62]

-5.39∗∗
[-9.09,-1.69]
1.30
[-5.13,7.72]

-5.62∗∗
[-9.65,-1.58]

2.86∗
[1.15,7.08]

0.67
[0.29,1.56]
0.62
[0.18,2.19]

0.70
[0.31,1.59]
0.73
[0.25,2.10]

0.24+
[0.054,1.03]

1.88∗
[1.06,3.33]

2.88∗∗
[1.42,5.85]

1.57
[0.86,2.85]

Persistence
of Stage 2
hypertension
2013–17
(Odds Ratio)

Hypertensive Stage 2

-5.59∗
[-11.1,-0.065]
-5.50
[-15.3,4.33]

Religion (Ref.: Christian)
Muslim

HIV status (Ref.: HIV-negative)
HIV-positive

1.49
[-1.68,4.66]

6.38∗
[1.16,11.6]

1.28
[0.86,1.91]

Change in
systolic
BP
2013–17
(OLS Coef)

Marital status (Ref.: Not currently married)
Currently married
1.19
[0.70,2.02]

0.99
[-1.44,3.42]

Persistence
of hypertension
2013–17
(Odds Ratio)

6.61∗∗
[1.99,11.2]

1.45+
[0.93,2.27]

Change in
systolic
BP
2013–17
(OLS Coef)

Hypertensive Stage 1 or 2

Body mass index (BMI), Categorical (Ref.: Normal weight or underweight)
Overweight/obese
2.49∗∗
4.72∗∗
1.82+
[1.55,4.01]
[1.31,8.14]
[0.96,3.45]

Gender (Ref.: Male)
Female

Onset of
hypertension
2013–17
(Odds Ratio)

Not hypertensive

Among 2013 respondents who are

Table 2: Predictors of changes in systolic blood pressure, onset and persistence of hypertension

Hypertension without Conventional Risk Factors
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Table 3: Average annual within-person change in blood pressure during 2013–17, by
2017 age group

Age (2013):

45–54

55–64

65–74

Average annual within-person change in systolic BP:
Women
0.94**
0.14
0.41
[0.45,1.44]
[-0.53,0.81] [-0.77,1.59]
Men
0.03
0.27
-0.05
[-0.68,0.75] [-0.50,1.04] [-1.16,1.05]

75+

Pooled
45+

-0.80
[-0.77,1.59]
-0.22
[-1.60,1.15]

0.38+
[-0.033,0.79]
0.07
[-0.77,1.59]

Average annual within-person change in diastolic BP:
Women
-0.14
-0.67**
-0.41
-0.63*
[-0.43,0.14] [-1.04,-0.30] [-0.95,0.12] [-1.24,-0.019]
Men
-0.61**
-0.92**
-0.76**
-0.53
[-1.03,-0.20] [-1.36,-0.48] [-1.24,-0.28]
[-1.18,0.12]

-0.42**
[-0.62,-0.21]
-0.74**
[-0.97,-0.51]

p-values: + p < 0.10, ∗ p < 0.05, ∗∗ p < 0.01. 95% confidence intervals are estimated based on robust
standard errors clustered at the village level. Analyses include all MLSFH-MAC respondents with
both 2013 and 2017 BP measurement. Within-person change in BP is calculated as the difference of
2017 BP minus 2013 BP. Outliers in BP change are eliminated as they may reflect measurement errors
(outliers are defined as being in the 1st or 99th percentile of the 2013–17 change in BP.

in Western, but more than that in some other low-income populations [29]). There is no
systematic age-related increase for men, or women aged 55+. Diastolic blood pressure declines on average as respondents age. Identical conclusions are obtained comparing the
adjacent box plots in Figure 2 that show 2013 and 2017 BP among longitudinally followed
individuals: there is only minimal change in the distribution of systolic BP as cohort members aged during 2013–17, while diastolic BP declined as the cohort got older.
In combination, Table 3 and Figure 2 indicate that there is no increase in average hypertension risk in the MLSFH-MAC cohort as cohort members aged four years during
2013–17. While hypertension is highly prevalent and often persistent among MLSFH mature adults (Table 1), overall hypertension was not worsening in the MLSFH-MAC cohort:
The distribution of hypertension categories in 2017 is indistinguishable from that in 2013
(p(χ2 ) = .94) for cohort members who survived and had BP measured at both waves
(Table S.5).
Contrasting cohort and cross-sectional patterns in hypertension: In contrast to the rela-

tively “flat” hypertension profile as the cohort got older during 2013–17, there is a strong
cross-sectional increase in systolic BP and hypertension with age. For instance, 54.3% adults
aged 45–54 had systolic BP of 120 or higher in 2013, and only 22% had systolic BP of 140
or higher. At ages 75+, the respective factions are 78.1% (p < .01) and 52.5% (p < .01). The
cross-sectional age gradient for systolic BP is .73 (CI: .95–.87) per year of age in 2013, and
.077 (CI: .0062–.13) for diastolic BP (Table S.3). There is also a corresponding cross-sectional
increase in hypertension with age: 30% of adults aged 45–54 were hypertensive (Stage 1
or 2) in 2013, increasing to 54% (p < .01) at ages 75+. A 10 year higher age increases the
Version: 10th February, 2022 (11:52am)
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Figure 2: Systolic blood pressure (mmHg) among mature adults in 2013 and 2017, by
age in 2013

80

Systolic Blood Pressure (mmHg)
100 120 140 160 180

200

Systolic BP (mmHg): Cohort change by 10−year age groups

2013

2017

Age 45−54

2013

2017

Age 55−64

2013

2017

Age 65−74

2013

2017

Age 75+

Based on average of 3 blood pressure measurements

Notes: Analyses include all MLSFH-MAC respondents with both 2013 and 2017 BP
measurement. Age group is assigned based on age in 2013. Systolic BP is top-coded
at 200 mmHg. The corresponding graph for diastolic BP is reported in Supplemental
Figure S.1. Supplemental Figure S.2 and Figure S.3 provide analyses separate for men
and women.

odds of being hypertensive in the cross-section by about 42% (CI: 32–54%), with similar increases also pertaining to of stage 2 hypertension (Table S.3). This cross-sectional patterns
remains stable in 2017 (Table S.3).
The strong cross-sectional age gradient in BP is in contrast to the flat BP profile documented in our earlier longitudinal analyses (Table 3 and Figure 2). Specifically, this divergence of the BP age-gradient between cohort and cross-sectional analyses is suggestive of
potential cohort influences on BP and hypertension, that is, the possibility that the higher
BP and hypertension prevalence among older adults is due to higher levels of life-course
adversity experience by older persons. Such cohort effects are plausible because worse
early-life conditions among older cohorts has been linked to worse health outcomes at
older ages (including worse cardiovascular health) [30, 31]. This aspect is especially important in countries having experienced socioeconomic development or improvements in
health (and thus more pronounced cohort differences in early-life environments) during
the 20th century [32, 33]. For example, height, a common indicator of early-life nutritional
status that was measured in 2017, declines strongly in our study population with age (agegradient = -.15cm, p < .01, with controls for region and gender).
Blood pressure, hypertension prevalence and body mass index: Our earlier analyses have

shown that being overweight/obese or having high BMI is a risk factor factor for the onset
and persistence of hypertension during 2013–17 (Table 2), as well as for having elevated
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Figure 3: Body Mass Index (BMI) of MLSFH-MAC Respondents aged 2012–13

Body Mass Index (BMI)
15
20
25
30

35

Body Mass Index (BMI) by 10−year age groups

2012

2017

45−54

2012

2017

55−64

2012

2017

65−74

2012

2017

75+

Based on measured height and weight; # longitudional obs = 1,012

Notes: Based on measured height and weight in 2012 and 2017. Red line denotes the cut-off for
obesity (BMI≥30), and the blue line denotes the cut-off for overweight (25≤BMI≥30). Age group
is assigned based on age in 2017. Source: Kohler et al. [16]

blood pressure or being hypertensive (Table S.2). Yet, the overall high prevalence of hypertension among MLSFH Mature Adults contrasts sharply with an overall low prevalence of
adiposity (Figure 3). Only a small fraction of respondents are overweight (12% of the total
sample in 2017), and an even smaller fraction (4.7%) is obese. Above age 75, where the hypertension prevalence peaks, more than 25% of the respondents are underweight, and only
few are obese (2%). There is neither a cross-sectional increase of BMI with age, nor a substantive within-person change in BMI during 2012–17. Age-related increases in BMI are
not a factor driving the higher prevalence of hypertension at older ages, further confirming that other factors—such as worse early-life conditions or higher levels of life-course
adversity—are contributing to the higher levels of hypertension among older persons.
Consequences of being hypertensive: Hypertension predicts mortality in the MLSFH-

MAC cohort, with hypertensive individuals facing about 60% higher odds of dying during 2013–18 (Table 4). Importantly for our cohort analyses, hypertension does not predict
survey attrition for reasons other than mortality. Among survivors, hypertension at baseline is also associated with several adverse outcomes. For example, hypertension predicts
declines in subjective health and SF12 physical health score relative to non-hypertensive
cohort members during 2013–17, and it predicts (relative) increases in PHQ9 depression
score and GAD7 anxiety scores. There is also evidence that hypertension reduces effort
in common moderately-intensive work activities (e.g., time spent in animal care, firewood
preparation, planting, etc.) (Table 4). Baseline hypertension does not predict changes in
physical health indicators such as grip strength or BMI during 2013–17, nor does it predict
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Table 4: Consequences of baseline hypertension in MLSFH-MAC cohort 2013–17
2013–17 Change in:
Hypertension
in 2013 (baseline)

Stage 1 Hypertension
Stage 2 Hypertension
Observations

Subjective
health
(OLS Coef.)

SF12
Physical
health
score
(OLS Coef.)

PHQ9
Depression
score
(OLS Coef.)

1.28
[0.73,2.23]
1.03
[0.60,1.78]

0.013
[-0.17,0.20]
-0.22∗
[-0.40,-0.034]

-0.56
[-1.94,0.82]
-2.51∗∗
[-4.20,-0.83]

0.18
[-0.52,0.88]
1.04∗
[0.15,1.94]

1,227

1,108

1,104

1,108

Mortality
2013–18
(Odds Ratios)

Nonmortality
attrition
(Odds Ratios)

1.24
[0.78,1.97]
1.89∗∗
[1.19,2.98]
1,225

2013–17 Change in:

Stage 1 Hypertension
Stage 2 Hypertension
Observations

GAD7
Anxiety
score
(OLS Coef.)

Work
efforts
(hours/wk)
(OLS Coef.)

Grip
Strength
(OLS Coef.)

Body Mass
Index
(BMI)
(OLS Coef.)

ICA
Cognition
score
(OLS Coef.)

0.32
[-0.27,0.91]
0.96∗∗
[0.30,1.62]

-1.57
[-4.25,1.11]
-6.37∗∗
[-9.19,-3.55]

-0.18
[-0.92,0.56]
-0.13
[-0.94,0.68]

-0.025
[-0.40,0.35]
0.11
[-0.28,0.50]

0.13
[-0.44,0.71]
-0.069
[-0.81,0.68]

1,108

1,080

976

1,046

1,030

p-values: + p < 0.10, ∗ p < 0.05, ∗∗ p < 0.01. 95% confidence intervals are estimated based on robust
standard errors clustered at the village level. Analyses additionally control for age and gender.

changes in cognitive scores.
Awareness of hypertension and knowledge of associated health risks: Respondents at-

tribute significant value to knowing their BP, and around 60% report in 2013 a willingness
to walk up to 1 hour to obtain a BP measurement, and 1/3 reports a willingness to walk
more than 2 hours (Table 5). These reports are consistent with the almost universal consent to BP measurement as part of our study. This willingness does not increase among
respondents who are hypertensive, but it is consistent with respondents associating BP
with several dimensions of their overall health. However, not all of these associations are
accurate. For instance, about 37% of respondents in 2013 (33% in 2017) think that knowing
one’s BP may indicate being HIV-positive (Table 5), an association that is not generally established [34, 35]. More than 70% of baseline respondent correctly state that BP knowledge
can be informative about the with risk of stroke, heart disease, and diabetes. About 80%
of respondents think BP is informative about their ability to work and being productive in
daily life, in sharp contrast and the mostly asymptomatic nature of high BP (albeit there
is some evidence in our study population that stage 2 hypertension leads to reductions in
work effort; Table 4). About 46% of baseline respondents associate BP with malaria, an association that is empirically tenuous [36]. Notably, these assessments about the importance
of knowing ones BP do not differ by respondent’s own hypertension status: hypertensive
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Table 5: Awareness of hypertension and knowledge of the risks associated wih high
blood pressure in MLSFH-MAC cohort with 2013 and 2017 blood pressure measurement
Respondent is

If a government clinic offering blood pressure
measurement were available nearby, would
you get your blood pressure measured if you
had to walk:
1 hour
2 hours
More than 2 hours

Not
hypertensive

Hypertensive

Combined

63%
45%
36%

59%
45%
34%

62%
45%
35%

37%
76%
78%
87%
70%
45%

35%
70%
79%
88%
74%
47%

36%
73%
79%
87%
72%
46%

33%
64%
71%
73%
46%
34%

29%
65%
74%
77%
44%
33%

31%
64%
72%
75%
45%
34%

Why do you think that it might be important
for individuals to know their blood pressure?
It may tell them...
2013:
...if they have HIV
...about their risk of stroke
...something about how much they can work
...if they have heart problems
...if they have diabetes
...if they have malaria
2017:
...if they have HIV
...about their risk of stroke
...something about how much they can work
...if they have heart problems
...if they have diabetes
...if they have malaria

individuals do not state more accurate reasons of why it is important to know BP, nor do
they give more importance to BP knowledge. At follow-up in 2017, respondents report
similar associations of blood pressure with other health outcomes as in 2013, albeit overall
there is a declining perception that knowledge about BP can be indicative of other health
issues.
Cascade of care for hypertension: There remain substantial gaps in the diagnosis and

treatment of hypertension among adults aged 45+ in rural Malawi (Figure 4A). Among
all respondents who were identified as hypertensive in 2013, only 22% have been diagnosed in the last 2 years by a doctor or medical professional as hypertensive (red bar).
Among those who were diagnosed, less then 9% reported in 2013 to be taking treatment
for hypertension (green bar); that is for about 61% of respondents their medical needs for
disease treatment were not met in 2013. Among those who were on treatment, only 11%
had BP levels “under control,” i.e., within the normal range. The cascade for 2017 among
cohort respondents shows an overall improved cascade (Figure 4B), but there remain subVersion: 10th February, 2022 (11:52am)
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Figure 4: Cascade of care for hypertension in rural Malawi, cohort respondents age 45+
yrs. 2013–17
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0
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22.2

All hypertensive
Taking treatment
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All hypertensive
Taking treatment
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Notes: The cascade represents the proportion of individuals who reach each separate stage of care, conditional
on being included in the previous stage. Analyses are based on respondents who participated in both the 2013
and 2017 MLSFH-MAC to ensure that variations in the study populations do not affect the findings; however,
similar patterns are identified based on analyses of all 2013 or 2017 respondents.

stantial gaps in care: only 58% of respondents with measured high levels of BP were not
diagnosed in the past as hypertensive, and 54% of the diagnosed do not report taking treatment. However, only 17% of hypertensive respondents have attained a measured BP in the
normal range. In a related study we have has documented that prior testing—and specifically the receipt of referral letters to health care providers—helped reduce blood pressure,
increase diagnoses and update of medication [12] (similar findings have also been shown
in South Africa [13]). The blood pressure screening that was conducted as part of the
MLSFH-MAC may therefore have been instrumental in achieving improvements in case
between 2013 and 2017 (Figure 4A+B).

4. S UMMARY AND D ISCUSSION
Cardiovascular diseases (CVDs) are rapidly becoming a major source of morbidity and
mortality in many Sub-Saharan African (SSA) countries, while disease burdens attributable
to communicable diseases are decreasing [8]. Addressing the implications of this shifting
disease burden, which occurs together with a rapid aging of SSA populations, is critical
for achieving the “grand convergence” in health that has been proposed as an achievable global health goal by 2035 [37]. Importantly, a renewed focus on NCDs—including
hypertension as a top priority—will be critical as the Covid-19 pandemic has further revealed the incredible challenges of addressing a dual burden of communicable and noncommunicable diseases in LICs [38], as well as the health and social vulnerabilities in LIC
population that are caused by an often inadequately treated burden of noncommunicable
diseases [39].
The rural subsistence agriculture population that is the focus of this study has low
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levels of modernization, very limited exposure to “classic” risk factors such as fast food
consumption/unhealthy life styles, and is characterized by high levels of physical activity.
Hypertension in such low-income populations has rarely been investigated using longitudinal data, and this is especially the case for older persons who are most at risk of cardiovascular diseases. Drawing on MLSFH-MAC panel data, this study is able to fill an
important niche in the literature by highlighting cohort patterns of hypertension and highlighting the dynamics of onset and persistence of hypertension as individuals age during
2013–17.
Key findings of our analyses of blood pressure in this aging poor SSA population pertain to several domains of hypertension research: (1) Prevalence of hypertension and its
predictors: Hypertension is highly prevalent among individuals aged 45+, with more than
40% being hypertensive and more than 30% being pre-hypertensive. These high rates of
hypertension affect both men and women age 45+, in contrast to strong gender differences
that have been documented in higher-income populations (Figure 1A). In our study population, the prevalence of hypertension is much higher than that of being overweight or
obese, and while being overweight/obese is a predictor of hypertension, the higher prevalence of hypertension at older ages is not associated with higher levels of adiposity at older
ages.
(2) Hypertension and aging—longitudinal changes in blood pressure: (a) While there
is a strong cross-sectional age gradients in blood pressure and hypertension, with older
individuals having worse cardiovascular health, our longitudinal analyses using MLSFHMAC data 2013–17 that on average a relatively flat profile of blood pressure or hypertension. As cohort members aged during 2012–17, there is no discernible increase in average
blood pressure or the prevalence of hypertension: among longitudinally followed MLSFHMAC respondents, the distribution of hypertension categories in 2017 is indistinguishable
from that in 2013. The aging of the cohort during 2013–17 did therefore not increase average blood-pressure-related cardiovascular risk in this poor study population. (b) This divergence of cross-sectional and longitudinal age-gradient in BP and hypertension is likely
due to cohort influences: earlier cohorts had worse early-life environments that, consistent
with the Barker hypotheses [40], translated into worse cardiovascular health at older ages.
(c) Despite the relatively stable distribution of blood pressure as the MLSFH-MAC cohort
aged during 2021–17, blood-pressure-related cardiovascular risk is dynamic on the individual level. Among respondents with normal BP in 2013, about 10% experienced an onset of hypertension by 2017; among pre-hypertensive respondents in 2013, this rate almost
triples and 28.5% experienced an onset of hypertension. (d) Stage 1 or 2 Hypertension,
however, are often persistent: 59% of respondents with Stage 1 hypertension in 2013 were
still hypertensive in 2017, and this is the case for 84% of respondents with Stage 2 hypertension at baseline in 2013. (e) The overall stable hypertension profile in the MLSFH-MAC
cohort during 2013–17 arises because the onset of hypertension is compensated by who
experience a decline in blood pressure or a transition from being hypertensive to normal
blood pressure or pre-hypertension.
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(3) Predictors of onset of hypertension over time: (a) Being overweight/obese is a
strong predictor of the onset and persistence of hypertension during 2012–17, and poor
physical health (low S12 physical score) and facing nutritional stress (not having eaten fish
or meat in last 7 days at baseline) predicts the onset of hypertension. Being HIV-positive
or Muslim implies lower odds of experiencing increases in systolic BP. Interestingly, marriage may not be protective for cardiovascular health, in contrast to a common finding in
other populations [28]. Being currently married in our study population is associated with
increasing blood pressure over time and the persistence of hypertension. (b) Nevertheless,
there are few systematic socioeconomic predictors of the onset or persistence of hypertension
in this study population aged 45+ during 2013–17; notably neither schooling, wealth, nor
grip strength (all measured in 2013) predict the onset/persistence of hypertension during
2013–17 or changes in systolic/diastolic blood pressure (albeit these factors predict crosssectional level differences in BP or hypertension prevalence in the expected direction).
(4) Life-course conseuqences of hypertension: Importantly, hypertension is has measurable consequences among adults aged 45+ in Malawi. Hypertension for example predicts
mortality in the MLSFH-MAC population during 2013–17, with hypertensive individuals
facing about 60% higher odds of dying. Yet, hypertension is not associated with nonmortality attrition in the MLSFH-MAC. Hypertension at baseline also associated with declines in subjective health, SF12 physical health scores and work efforts during 2013–17
and it is associated with increases in depression and anxiety. These findings thus reaffirm
that hypertension is an important public health concern among adults aged 45+ in rural
Malawi that is associated with more rapid declines in health as individuals get older.
(5) Cascade of hypertension care: While diagnoses and treatment of hypertension are
improving, our analyses of the cascade of care document that there remain substantial gaps
in the diagnosis and treatment of hypertension among adults aged 45+ in rural Malawi.
In 2013, for example, only 22% have been diagnosed in the last two years by a doctor or
medical professional as hypertensive, and among those who were diagnosed, less then
9% reported in 2013 to be taking treatment for hypertension. Yet, this cascade of care
substantially improved by 2017. 43% of hypertensive individuals were diagnosed, and
46% of the diagnosed were taking treatments. Yet, despite these improvements in the
cascade of care, only 17% of hypertensive respondents have attained a measured BP in the
normal range. These gaps in the cascade of care are disconcerting as high blood pressure
is one of the main modifiable causes of cardiovascular disease risk with a large body of
evidence showing that lowering blood pressure through low-cost and widely available
medications significantly reduces CVD mortality [41].
Overall, our findings in this paper indicate that hypertension and related high cardiovascular risks are widespread, persistent and often not diagnosed or treated in this rural
sub-Saharan population aged 45+. The prevalence, onset and persistence of hypertension cuts across all subgroups in this population—including, importantly, both women
and men. While age is an important predictor of hypertension risk, as has been documented in other LMIC contexts [7], hypertension is already widespread in in middle ages
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45–55 years. Hence, hypertension among adults 45+ in Malawi seems to be more similar to a “generalized epidemic” than in high-income countries where cardiovascular risk
has strong socioeconomic gradients and untreated hypertension particularly prevalent in
vulnerable subsets of older persons [42].
Yet, our findings do not provide a bleak picture about hypertension and cardiovascular
disease risk in poor aging populations in SSA or elsewhere. In contrast, a recent body of
research has started to provide evidence that relatively inexpensive screenings and referrals for hypertension and are effective approach to reduce the gaps in the cascade of care
for hypertension [12, 13]. Our findings highlight the urgency of building on this recent evidence and expand information about cardiovascular risk, screening for hypertension and
available treatments for elevated blood pressure to the global poor. Such efforts are likely
to have large returns in terms of improving population health among older persons [37].
Some limitations of our study are noteworthy. While the MLSFH-MAC is based on
a large, population-based sample of adults 45+ years old living in a rural SSA LIC context, it is not a nationally representative sample. This concern is somewhat ameliorated by
the fact that the MLSFH-MAC cohort characteristics closely match that of cross-sectional
nationally-representative samples [16] and the fact that roughly 85% of the Malawian population resides in rural areas [43]. Hence, our findings can likely be generalized to other
rural areas in Malawi and similar low-income populations in southeastern SSA. The age
range covered in our study (age 45+ years) is also comparable to other aging studies in
SSA LICs [44], and given life expectancy trends in Malawi and SSA more generally, the
study represents adequately the experience of the older population in the region. As in
any longitudinal study, attrition is a concern for the MLSFH. However, non-mortalityrelated attrition has been very low in the MLSFH-MAC as a result of migration tracking
and related fieldwork procedures; during 2012–18 the MLSFH-MAC retained 97% of surviving respondents [16]; importantly, non-mortality-related attrition 2013–17 is not associated with hypertension. Detailed analyses of attrition as part of the MLSFH cohort profiles
[16, 20] have also shown that, even though respondent characteristics often differ significantly between those who were lost to follow-up and those who were re-interviewed, the
coefficient estimates for standard family background variables in regressions and probit
equations for many health outcomes are not significantly affected by attrition.
Population-based blood pressure measurement in rural older and poor populations in
challenging, and measurements of blood pressure on a single session—as is conducted in
most population-based health surveys, including the MLSFH—does not provide a clinical diagnoses of hypertension. Yet the MLSFH-MAC adopted the protocol for Health and
Retirement Study [25], and through extensive training and carefully-developed fieldwork
logistics, the MLSFH-MAC not only achieved very high rates of consent to blood pressure
measurements, and data quality of the blood pressure measures is generally high [16].
However, the MLSFH-MAC data lack details about how individuals are affected by hypertension, and among those who are treatment, what specific type of hypertension they
receive and/or how frequently they are followed up by the health system.
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Given the scarcity of longitudinal data on blood pressure and hypertension in SSA lowincome populations, the limitations of this study are relatively minor. The MLSFH-MAC
is one of the rare cohort studies in a SSA LICs that provides detailed longitudinal information about blood pressure, hypertension knowledge and treatment, and our analyses
are among the first that document the cohort patterns of hypertension in an aging SSA LIC
population.
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Figure S.1: Diastolic blood pressure (mmHg) among mature adults in 2013 and 2017,
by age in 2013
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Systolic BP (mmHg): Women
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Figure S.2: Systolic blood pressure (BP mmHg) among mature adults in 2013 and 2017,
by gender and age in 2013
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Notes: Analyses include all MLSFH-MAC respondents with both 2013 and 2017 BP
measurement. Age group is assigned based on age in 2013. Systolic BP is top-coded at
200 mmHg.
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Figure S.3: Diastolic blood pressure (BP mmHg) among mature adults in 2013 and 2017,
by gender and age in 2013
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Notes: Analyses include all MLSFH-MAC respondents with both 2013 and 2017 BP
measurement. Age group is assigned based on age in 2013. Diastolic BP is top-coded
at 110 mmHg.
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Table S.1: Summary statistics for the MLSFH Mature Adult Cohort in 2017 (respondents with BP measurement), and bivariate associations with systolic and diastolic
blood pressure
2017 MLSFH Mature Adults
Bivariate association
with blood pressure
# of observations
Age
Age Group
45–54
55–64
65–74
75+
Schooling attainment
No formal schooling
Primary schooling
Secondary or higher
Muslim
Currently married
Wealth indicator: House has metal/tiled roof
Respondent is female
Region
Mchinji
Balaka
Rumphi

Women

Men

Total

Systolic

Diastolic

910
60.4
(11.9)

602
60.9
(11.5)

1,512
60.6
(11.7)

0.38
0.30
0.18
0.14

0.36
0.28
0.21
0.15

0.37
0.29
0.19
0.14

Ref.
7.73∗∗
14.4∗∗
19.8∗∗

Ref.
1.04
1.99∗
1.53

0.37
0.60
0.03
0.26
0.58
0.48
–

0.19
0.70
0.12
0.23
0.94
0.51
–

0.30
0.64
0.06
0.25
0.72
0.49
0.60

Ref.
-5.27∗∗
-3.56
4.15∗∗
-2.32
2.46+
-0.98

Ref.
-1.14
0.58
1.56∗
-0.18
0.96
0.97

0.30
0.36
0.34

0.37
0.29
0.34

0.33
0.34
0.34

Ref.
5.88∗∗
-0.51

Ref.
1.92∗
0.14

Notes: Bivariate associations in Columns 4–5 are estimated by regressing systolic or diastolic blood pressure individually on age (linear), age group (categorical), schooling attainment, being muslim, being currently married, having a metal roof and being female. p-values (robust std. errors): p < 0.10, ∗ p < 0.05,
∗∗ p < 0.01.
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Table S.2: Health indicators for the MLSFH Mature Adult Cohort in 2017 (respondents
with BP measurement), and associations with systolic and diastolic blood pressur
2017 MLSFH Mature Adults
Association
with blood pressure
# of observations
Systolic blood pressure
(mean of 3 measurements)
Diastolic blood pressure
(mean of 3 measurements)
Body Mass Index
Underweight (BMI<18.5)
Normal (18.5 ≤BMI<25)
Overweight (25≤BMI<30)
Obese (BMI≥30)
Grip strength (average both hands)
Subjective health
very poor
poor
good
very good
excellent
Subjective well-being
Very unsatisfied
Somwhat unsatisfied
Satisfied
Somwhat satisfied
Very satisfied
Ill in past 12 months
No illness
Ill for < 1 month
Ill for 1–3 months
Ill for > 3 months
HIV positive

Women

Men

Total

Systolic

Diastolic

910
132.9
(25.4)
84.0
(12.9)

602
133.8
(22.9)
83.0
(11.8)

1512
133.3
(24.5)
83.6
(12.5)

0.16
0.62
0.15
0.068
19.8
(5.24)

0.18
0.73
0.079
0.015
27.0
(6.35)

0.17
0.66
0.12
0.047
22.7
(6.71)

Ref.
0.76
8.38∗∗
12.4∗∗
0.33∗∗

Ref.
-0.040
4.50∗∗
7.88∗∗
0.17∗∗

0.078
0.26
0.44
0.17
0.056

0.058
0.18
0.44
0.26
0.062

0.070
0.23
0.44
0.21
0.058

Ref.
-0.39
-3.06
-2.84
-5.61

Ref.
-0.080
-1.02
-1.26
-1.91

0.013
0.13
0.34
0.31
0.20

0.017
0.12
0.25
0.33
0.28

0.015
0.13
0.30
0.32
0.24

Ref.
2.50
1.38
0.65
-0.021

Ref.
1.54
1.18
0.26
0.24

0.30
0.53
0.12
0.051
0.082

0.41
0.47
0.076
0.047
0.080

0.34
0.51
0.10
0.049
0.082

Ref.
1.04
-0.64
0.71
-8.73∗∗

Ref.
-0.041
-0.81
-0.98
-4.16∗∗

Notes: Associations in Columns 4–5 are estimated by regressing systolic or diastolic blood pressure
individually body mass index, grip strength, subjective health, subjective well-being, illness and
HIV status, controlling for age, gender and MLSFH study region. p-values (robust std. errors):
p < 0.10, ∗ p < 0.05, ∗∗ p < 0.01.
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Table S.3: Cross-sectional association of blood pressure and hypertension with age,
2013 and 2017
Blood Pressure

Stage 1 or 2

Stage 2

Systolic
(OLS Coef)

Diastolic
(OLS Coef)

Hypertension
(Odds Ratio)

Hypertension
(Odds Ratio)

2013 (Cross section, no controls)
Age
0.73∗∗
[0.59,0.87]
Observations
1227

0.077∗
[0.0070,0.15]
1227

1.04∗∗
[1.03,1.05]
1227

1.04∗∗
[1.03,1.06]
1227

0.070∗
[0.0005,0.14]
-0.007
[-1.80,1.78]
0.74
[-1.01,2.48]

1.04∗∗
[1.03,1.05]
0.98
[0.73,1.32]
0.96
[0.71,1.31]

1.04∗∗
[1.03,1.06]
0.94
[0.66,1.35]
1.23
[0.88,1.73]

1.06
[-0.92,3.03]
-2.06+
[-4.31,0.19]
1226

1.36∗
[1.02,1.82]
0.69∗
[0.49,0.97]
1226

1.06
[0.71,1.57]
0.51∗∗
[0.34,0.76]
1226

0.087∗∗
[0.026,0.15]
1512

1.05∗∗
[1.04,1.06]
1512

1.05∗∗
[1.03,1.06]
1512

0.082∗∗
[0.025,0.14]
0.45
[-1.17,2.08]
1.06
[-0.27,2.39]

1.05∗∗
[1.04,1.06]
0.85
[0.66,1.10]
0.99
[0.77,1.28]

1.05∗∗
[1.03,1.06]
0.99
[0.72,1.37]
1.03
[0.74,1.44]

1.91∗
[0.098,3.72]
-0.033
[-1.75,1.69]
1506

1.19
[0.90,1.58]
1.06
[0.81,1.37]
1506

1.24
[0.86,1.78]
0.89
[0.60,1.31]
1506

2013 (Cross section, basic controls)
Age
0.70∗∗
[0.57,0.84]
Any schooling
-0.25
[-3.75,3.25]
Female
0.51
[-2.83,3.85]
Region (Ref.: Mchinji)
Balaka
4.50∗
[0.13,8.87]
Rumphi
-5.89∗∗
[-10.0,-1.74]
Observations
1226
2017 (Cross section, no controls)
Age
0.71∗∗
[0.58,0.83]
Observations
1512
2017 (Cross section, basic controls)
Age
0.68∗∗
[0.57,0.80]
Any schooling
-0.65
[-3.74,2.43]
Female
-0.87
[-3.47,1.73]
Region (Ref.: Mchinji)
Balaka
4.88∗∗
[1.52,8.24]
Rumphi
0.19
[-2.62,3.00]
Observations
1506

Notes: OLS regression or logistic regression of 2013 or 2017 hypertension on the covariates included in
the table. p-values (robust std. errors): + p < 0.10, ∗ p < 0.05, ∗∗ p < 0.01.
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Table S.4: Prevalence of hypertension in 2013, by gender, and onset and persistence of
hypertension during 2013–17, by gender
Prevalence of
Hypertension

Women
Normal blood pressure
Pre-hypertension
Stage 1 hypertension
State 2 Hypertension

2013
Baseline
Sample

2013
Longitud.
Sample

Onset
Hypertension

Persistent
Hypertension

Persistent
Stage 2
Hypertens.

26.5%ns
31.4%ns
21.8%ns
20.3%ns

27.0%ns
32.4%ns
22.0%ns
18.6%ns

9.4%ns
34.1%∗∗
–
–

–
–
59.7%ns
85.6%ns

–
–
–
62.7%ns

706

633

23.7%ns
33.1%ns
25.8%ns
17.4%ns

24.5%ns
33.8%ns
25.0%ns
16.7%ns

12.3%ns
20.6%∗∗
–
–

–
–
58.3%ns
79.2%ns

–
–
–
51.4%ns

523

432

Obs (N)
Men
Normal blood pressure
Pre-hypertension
Stage 1 hypertension
State 2 Hypertension

Change in Hypertension 2013–17
(Longitudinal Sample)

Obs (N)

p-values for test for equality between women and men: + p < 0.10, ∗ p < 0.05, ∗∗ p < 0.01, ns difference
not statistically different at 10%.

Table S.5: Prevalence of hypertension in 2013 and 2017 among MLSFH Mature Adults
with blood pressure measurement in both years
Year
Normal blood pressure
Pre-hypertension
Stage 1 hypertension
State 2 hypertension
Observations (N)
Pearson

χ2 (3)

2013

2017

Combined

26.0%
33.0%
23.2%
17.8%

25.3%
34.1%
23.3%
17.4%

25.6%
33.5%
23.2%
17.6%

1,065

1,065

= 0.39, p-value = 0.94
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Table S.6: Predictors of changes in systolic blood pressure, onset and persistence of hypertension (additional findings)
Among 2013 respondents who are
Not hypertensive

Hypertensive Stage 1 or 2

All respondents
Hypertensive Stage 2

Combined

Change in
systolic
BP
2013–17
(OLS Coef)

Persistence
of hypertension
2013–17
(Odds Ratio)

Change in
systolic
BP
2013–17
(OLS Coef)

Persistence
of Stage 2
hypertension
2013–17
(Odds Ratio)

Change in
systolic
BP
2013–17
(OLS Coef)

Change in
systolic
BP
2013–17
(OLS Coef)

Change in
diastolic
BP
2013–17
(OLS Coef)

0.73
[0.41,1.30]

-1.20
[-4.36,1.97]

0.92
[0.55,1.55]

2.38
[-2.83,7.59]

1.37
[0.69,2.74]

2.52
[-5.51,10.6]

0.51
[-2.49,3.51]

0.16
[-1.26,1.58]

Wealth (z-score, based on 14-item asset ownership)
Wealth (z-score)
1.20
[0.96,1.50]

0.68
[-0.73,2.09]

1.10
[0.86,1.40]

1.87+
[-0.12,3.85]

1.35
[0.93,1.94]

2.14
[-1.64,5.91]

1.20+
[-0.066,2.46]

0.35
[-0.34,1.04]

1.39
[0.91,2.11]

1.48
[-1.34,4.29]

1.60+
[0.96,2.65]

2.44
[-2.28,7.16]

0.93
[0.44,1.98]

0.053
[-7.99,8.10]

1.99
[-0.61,4.60]

1.02
[-0.27,2.32]

1.01
[0.97,1.05]

0.046
[-0.23,0.32]

1.02
[0.96,1.07]

-0.059
[-0.50,0.38]

1.04
[0.97,1.12]

0.20
[-0.53,0.94]

-0.053
[-0.29,0.19]

-0.045
[-0.19,0.10]

≈625

≈620

≈435

≈410

≈190

≈175

≈1030

≈1030

Schooling (Ref.: No formal schooling)
At least some formal schooling (primary
or secondary)

Wealth (house with metal roof; Ref.: none)
Metal roof
Grip strength (average both hands)
Grip strength
Observations

Notes: Tables shows the results of OLS regressions (for change in blood pressure) or logistic regressions (for onset or persistence of hypertension) on the on
the predictor variables, controlling additionally for age, gender and region. level. Analyses include all MLSFH-MAC respondents with both 2013 and 2017 BP
measurement. Within-person change in BP is calculated as the difference of 2017 BP minus 2013 BP. Outliers in BP change are eliminated as they may reflect
measurement errors (outliers are defined as being in the 1st or 99th percentile of the 2013–17 change in BP. p-values (robust std. errors): p < 0.10, ∗ p < 0.05, ∗∗
p < 0.01.
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